Studies Will Support Investigational New Drug Application (IND) with the US FDA, Including Design of Phase 2 TrialTORONTO, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: ...

Zydus Lifesciences share price will remain in focus on December 24 following the company's wholly owned subsidiary entered into a strategic partnership with Swiss biopharmaceutical company.

Can-Fite BioPharma ( ($CANF) ) has issued an announcement. On December 23, 2025, Can-Fite BioPharma announced that, following shareholder approval ...

GC Biopharma (006280.KS), a leading global biopharmaceutical company, announced today that Ministry of Food and Drug Safety (MFDS) in South Korea has approved the Investigational New Drug (IND) ...

Analysts see little effect on the bottom lines of biopharma companies, as they stand to stave off tariff pressure and receive ...

Jillian Lauren speaks out after being shot by police, filing for divorce from Weezer bassist Scott Shriner Nicki Minaj's body ...

The SEC sued six individuals for running a multimillion-dollar insider trading and market manipulation scheme involving biopharmaceutical companies.

The headquarters for Boehringer Ingelheim in Ridgfield. Photo courtesy of Boehringer Ingelheim RIDGEFIELD – The biopharmaceutical company Boehringer Ingelheim will ...

December 22, 2025 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"),understands that Quantum ...

Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic ...

Propanc Biopharma, Inc. (Nasdaq: PPCB) is developing a novel approach to preventing cancer recurrence and metastasis by targeting and eradicating cancer stem cells through proenzyme activation. The ...

Xeris Biopharma’s Q3 gross margin improved to 85%. It has raised 2025 guidance to $285–290M, but shares fell 30%. See more on ...